Heat Biologics (HTBX) Announces Presentation of Topline HS-410 Phase 2 Bladder Cancer Results
Go back to Heat Biologics (HTBX) Announces Presentation of Topline HS-410 Phase 2 Bladder Cancer ResultsHEAT BIOLOGICS (NASDAQ: HTBX) | Delayed: 2.83 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $2.83 | 52 Week High | $4.71 | |||
Open | $2.83 | 52 Week Low | $0.40 | |||
Day High | $2.83 | P/E | N/A | |||
Day Low | $2.83 | EPS | $-0.50 | |||
Volume | 442,793 |